- Home
- RGNX vs OLMA Comparison
RGNX vs OLMA Comparison
Compare RGNX & OLMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RGNX | OLMA |
|---|---|---|
| Founded | 2008 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 793.5M | 949.3M |
| IPO Year | 2015 | 2020 |
Fundamental Metrics
Financial Performance| Metric | RGNX | OLMA |
|---|---|---|
| Price | $7.13 | $6.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 12 |
| Target Price | $23.58 | ★ $36.50 |
| AVG Volume (30 Days) | ★ 1.3M | 1.1M |
| Earning Date | 11-05-2026 | 11-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 18.08 | 15.00 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $10,393,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $22.42 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 126.48 | N/A |
| 52 Week Low | $5.46 | $6.48 |
| 52 Week High | $16.19 | $36.26 |
Technical Indicators
Market Signals| Indicator | RGNX | OLMA |
|---|---|---|
| Relative Strength Index (RSI) | 41.44 | 30.81 |
| Support Level | $6.96 | N/A |
| Resistance Level | $7.32 | $11.27 |
| Average True Range (ATR) | 0.48 | 0.43 |
| MACD | 0.04 | 0.03 |
| Stochastic Oscillator | 21.85 | 27.75 |
Price Performance
Historical ComparisonAbout RGNX REGENXBIO Inc.
Regenxbio Inc is a clinical-stage biotechnology company focused on the development of gene therapy treatments. Its product candidates are designed to deliver genes to cells to address genetic defects or enable the production of therapeutic proteins. The company is developing a pipeline of investigational gene therapy treatments using its NAV Technology Platform based on adeno-associated virus (AAV) vectors. Its internal research and development programs are focused on therapies for retinal, neuromuscular, and neurodegenerative diseases.
About OLMA Olema Pharmaceuticals Inc.
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.